Source:http://linkedlifedata.com/resource/pubmed/id/15166120
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2004-8-23
|
pubmed:abstractText |
GH is the major regulator of circulating IGF-I, which, in return, controls pituitary GH secretion by negative feedback. IGF-binding protein-1 (IGFBP-1) is believed to modify this feedback through its effects on free IGF-I. In the present study we investigated the potential influence of IGFBP-1 on GH secretion in the absence or presence of a GH receptor antagonist (GHRA) that specifically blocks peripheral GH action. We administered human (h) IGFBP-1 and GHRA to mice alone or in combination for 2 or 7 d. GHRA was administered in a dose previously shown to block GH action without an effect on circulating GH or IGF-I levels. hIGFBP-1 administration increased stimulated circulating GH levels and serum total IGF-I and IGFBP-3 levels. Coadministration of GHRA abolished the hIGFBP-1-induced increase in serum IGF-I and IGFBP-3 levels, whereas stimulated GH levels remained increased. Free IGF-I levels in serum were unchanged in all treatment groups. In conclusion, GH serum levels increased in response to hIGFBP-1 administration, even in the setting of normal IGF-I levels. This finding suggests a direct involvement of IGFBP-1 in GH secretion.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Growth Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor Binding...,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor Binding...,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0013-7227
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
145
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4401-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15166120-Animals,
pubmed-meshheading:15166120-Blood Glucose,
pubmed-meshheading:15166120-Eating,
pubmed-meshheading:15166120-Feedback, Physiological,
pubmed-meshheading:15166120-Female,
pubmed-meshheading:15166120-Gene Expression,
pubmed-meshheading:15166120-Growth Hormone,
pubmed-meshheading:15166120-Humans,
pubmed-meshheading:15166120-Insulin,
pubmed-meshheading:15166120-Insulin-Like Growth Factor Binding Protein 1,
pubmed-meshheading:15166120-Insulin-Like Growth Factor Binding Protein 3,
pubmed-meshheading:15166120-Insulin-Like Growth Factor I,
pubmed-meshheading:15166120-Kidney,
pubmed-meshheading:15166120-Liver,
pubmed-meshheading:15166120-Mice,
pubmed-meshheading:15166120-Mice, Inbred BALB C,
pubmed-meshheading:15166120-Organ Size
|
pubmed:year |
2004
|
pubmed:articleTitle |
Administration of human insulin-like growth factor-binding protein-1 increases circulating levels of growth hormone in mice.
|
pubmed:affiliation |
Laboratory of Pediatrics, Subdivision of Molecular Endocrinology, Erasmus Medical Center, 3000 DR Rotterdam, Rotterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|